화학공학소재연구정보센터
Journal of Industrial and Engineering Chemistry, Vol.64, 438-445, August, 2018
Preparation and anticancer effect of pegylated-chlorambucil prodrug nanoparticle for enhanced therapeutic efficiency
E-mail:
Chlorambucil (CLB), which is well known as a therapeutic agent of leukemia and Hodgkin’s disease, has been reported to have anticancer effects against various cancer cells. However, hydrophobic CLB has many problems, including being inefficient and producing side effects because of its low solubility in water. For these reasons, we developed a pegylated-CLB (PCLB and mPCLB) prodrug nanoparticle, which demonstrated excellent dispersibility, high anticancer activity and superior intracellular uptake. These results suggest that PCLB and mPCLB prodrug can use as anticancer agents against various cancer cells.
  1. Fabiilli ML, Haworth KJ, Sebastian IE, Kripfgans OD, Carson PL, Fowlkes JB, Ultrasound Med. Biol., 36, 1364 (2010)
  2. Guaragna A, Chiaviello A, Paolella C, D'Alonzo D, Palumbo G, Palumbo G, Bioconjug. Chem., 23, 84 (2012)
  3. Saha B, Haldar U, De P, Macromol. Rapid Commun., 37(13), 1015 (2016)
  4. Venkatesh Y, Karthik S, Rajesh Y, Mandal M, Jana A, Singh ND, Chem. Asian J., 11, 3482 (2016)
  5. Zhang Q, Zhang L, Li Z, Xie X, Gao X, Xu X, Y. Venkatesh, S. Karthik, Y. Rajesh, M. Mandal, A. Jana, N.D. Singh, 18, 2977 (2017)
  6. Soler M, Gonzalez-Bartulos M, Figueras E, Ribas X, Costas M, Massaguer A, Planas M, Feliu L, Org. Biomol. Chem., 13, 1470 (2015)
  7. Bisht R, Mandal A, Jaiswal JK, Rupenthal ID, Nanomed. Nanobiotechnol., 10 (2017)
  8. Dua K, Bebawy M, Awasthi R, Tekade RK, Tekade M, Gupta G, Pinto TDJA, Hansbro PM, Pharm. Nanotechnol., 5 (2017)
  9. Hervault A, Dunn AE, Lim M, Boyer C, Mott D, Maenosono S, Thanh NT, Nanoscale, 8, 12152 (2016)
  10. Kim TH, Jeong GW, Nah JW, J. Ind. Eng. Chem., 54, 298 (2017)
  11. Banerjee SS, Chen DH, Nanotechnology, 19, 265602 (2008)
  12. Jeong GW, Nah JW, Park JK, Appl. Chem. Eng., 28(4), 404 (2017)
  13. Sah AK, Vyas A, Suresh PK, Gidwani B, Artif. Cells Nanomed. Biotechnol., 1 (2017).
  14. Choi C, Nam JP, Nah JW, J. Ind. Eng. Chem., 33, 1 (2016)
  15. Choi C, Lee HY, Jeong YI, Nah JW, J. Ind. Eng. Chem., 47, 112 (2017)
  16. Fang J, Nakamura H, Maeda H, Adv. Drug Deliv. Rev., 63, 136 (2011)
  17. Maeda H, Bharate GY, Daruwalla J, Eur. J. Pharm. Biopharm., 71, 409 (2009)
  18. Chen J, Wu Q, Luo L, Wang Y, Zhong Y, Dai HB, Sun D, Luo ML, Wu W, Wang GX, Int. J. Nanomed., 12, 5745 (2017)
  19. Shen Z, Loe DT, Awino JK, Kroger M, Rouge JL, Li Y, Nanoscale, 8, 14821 (2016)
  20. Vasconcelos A, Vega E, Perez Y, Gomara MJ, Garcia ML, Haro I, Int. J. Nanomed., 10, 609 (2015)
  21. Hartveit F, Acta Pathol. Microbiol. Scand., 77, 639 (1969)
  22. Besterman JM, Low RB, Biochem. J., 210, 1 (1983)
  23. Bloom WS, Puszkin S, Mt. Sinai J. Med., 48, 397 (1981)
  24. Godlee C, Kaksonen M, J. Cell Biol., 203, 717 (2013)
  25. Schubert KO, Focking M, Prehn JH, Cotter DR, Mol. Psychiatry, 17, 669 (2012)
  26. Bach G, Pflugers Arch., 451, 313 (2005)
  27. Nakase I, Kobayashi NB, Takatani-Nakase T, Yoshida T, Sci. Rep., 5, 10300 (2015)
  28. Wu XM, Gehring W, Biochem. Biophys. Res. Commun., 443(4), 1136 (2014)
  29. Naota M, Shimada A, Morita T, Yamamoto Y, Inoue K, Takano H, Toxicol. Pathol., 41, 487 (2013)
  30. Hao X, Wu J, Shan Y, Cai M, Shang X, Jiang J, Wang H, J. Phys. Condens. Matter, 24, 164207 (2012)
  31. Kiss AL, Adv. Exp. Med. Biol., 729, 14 (2012)